Benznidazole
Benznidazole is a prescription oral tablet used to treat Chagas disease, an infection caused by the Trypanosoma cruzi parasite. Available in 12.5 mg and 100 mg strengths, it's manufactured by Exeltis USA, Inc. under NDA209570. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Benznidazole is a prescription oral tablet used to treat Chagas disease, an infection caused by the Trypanosoma cruzi parasite. Available in 12.5 mg and 100 mg strengths, it's manufactured by Exeltis USA, Inc. under NDA209570. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Benznidazole",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Benznidazole — ANDA 209570 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209570"
}
]
|
| identifier | ANDA209570 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"drug-safety",
"medications",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Benznidazole |
